Aclarion, Inc.
ACON Healthcare Health Information Services
Aclarion, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75,700.00, up 65.6% from fiscal 2024. In the quarter to June 2026, revenue grew 30.6%, EPS grew 59.3% and free cash flow fell 41.4%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow ACON
Aclarion, Inc. (ACON) EV/Sales
As of 16 October 2026, Aclarion, Inc. (ACON) trades at a EV/Sales of −137×. Over the past ten years it has ranged from −240× (April 2025) to 36,136,568× (September 2022); the current reading is higher than 12% of that period. That is below the Health Information Services industry median of 2.6× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | −123× | — |
| FY2024 | 20.9× | (28.62%) |
| FY2023 | 29.3× | — |
| FY2022 | −20.5× | — |
| FY2021 | 6,200,322× | 0.00% |
| FY2020 | 6,200,322× | 0.00% |
| FY2019 | 6,200,322× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | −107× | — |
| Mar 2026 | −152× | — |
| Dec 2025 | −123× | — |
| Sep 2025 | −100× | — |
| 20 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| ACON Aclarion, Inc. | −137× |
| HLTHQ Cue Health Inc. compare | −1.1× |
| ZCMD Zhongchao Inc. compare | −0.4× |
| ETAOF ETAO International Co., Ltd. compare | n/m |
| VSEED VSee Health, Inc. compare | 0.2× |
| HCTI Healthcare Triangle, Inc. compare | 0.4× |
| RNLXY Renalytix plc - Sponsored ADR compare | 2.5× |
| BFRG Bullfrog AI Holdings Inc. compare | 7.0× |
| MGRX Mangoceuticals, Inc. compare | 15.6× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)